ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Bausch Health Companies (BHC)
Bausch Health Companies stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · NYSE
$6.31▼ -0.63%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Bausch Health Companies in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Bausch Health Companies
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Bausch Health Companies a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $5.85 and $6.78; in 9 out of 10, between $5.13 and $7.73. Estimated annual volatility is 38%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $2.2B
- 52-week high
- $8.00
- 52-week low
- $4.33
- Revenue (12 months)
- $10.9B
- Revenue growth (YoY)
- +6.7%
- Gross margin
- 70.7%
- Operating margin
- 21.3%
- Net margin
- 1.2%
- Return on equity
- 41.6%
- Free cash flow (12 months)
- $1.4B
- Beta
- 0.37
What this means
ATLAS does not publish a fair value for BHC right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks BHC has traded between $4.33 and $8.00. Today it is 21.1% below that high and 46% above its low.
On the business: revenue grew 6.7% year over year; net margin is 1.2%.
Its beta is 0.37: it tends to move less than the market.
About the company
Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company focused on developing, manufacturing, and marketing healthcare products across multiple therapeutic areas.
Want to see everything about Bausch Health Companies?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Bausch Health Companies do?
Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company focused on developing, manufacturing, and marketing healthcare products across multiple therapeutic areas.
What is the chance BHC goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, BHC ends the month between $5.85 and $6.78.
How big is Bausch Health Companies and what is its P/E ratio?
Bausch Health Companies's market capitalization is $2.2B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is BHC?
ATLAS estimates annual volatility at 38%. In a typical month, half of the outcomes end between $5.85 and $6.78.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer